Details of the Drug Reposition

General Information of This Drug (ID: DMUTSRW)

Drug Name
Dexpanthenol   DMUTSRW
Synonyms
d-Pantothenol; (2S)-2,4-dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutanamide; L-Pantothenol; CAS-81-13-0; ( )-Panthenol; AC1NX8S7; KSC490G8B; SCHEMBL807508; CHEMBL1741351; CTK3J0380; SNPLKNRPJHDVJA-SSDOTTSWSA-N; ZINC1567243; ANW-37417; AKOS024438122; RTX-012330; NCGC00016326-01; AJ-27156; CJ-05387; UNII-WV9CM0O67Z component SNPLKNRPJHDVJA-SSDOTTSWSA-N
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
4 Approved Indication(s)
Indication Name Indication ID ICD-11 Status REF
Gastroparesis DISDW0SR DA41.00 Approved [1]
Skin disease DISDW8R6 EA00-EM0Z Approved [1]
Wound healing DISJPXO5 EL8Y Approved [2]
Amenorrhea DISBJQKZ GA20.0 Approved [1]
------------------------------------------------------------------------------------
1 Discontinued in Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Paralytic ileus DISPR3W9 N.A. Discontinued in Phase 2 [3]
------------------------------------------------------------------------------------

References

1 Riboflavin FDA Label
2 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
3 Hypogonadism in Young Men With Type 2 Diabetes